Access to research-grade retatrutide is restricted to qualified professionals operating within permitted research contexts
Researchers can utilize ELISAs in their labs to accurately measure active GLP-1
Because it targets GLP-1, GIP, and glucagon pathways, side effects and monitoring needs may be more complex than single-pathway medications
GLP-1s may not be suitable for people who: Have a history of pancreatitis Have certain thyroid conditions (e.g., medullary thyroid cancer) Are pregnant or breastfeeding (depending on the specific medication) Have severe gastrointestinal conditions, like gastroparesis GLP-1 receptor agonists, including Tirzepatide, have been shown to lead to significant weight loss, with many people losing 10-15% of their body weight over time
Do I need my doctor involved right away
Whether you are dealing with hot flashes, sleep disruption, brain fog, weight gain, or declining bone density, the goal is to restore balance and help you feel like yourself again